Rafai Far; Adel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rafai Far; Adel.The latest application filed is for "high purity oritavancin and method of producing same".

Company Profile

3.17.13

Rafai Far; Adel - Ville Saint Laurent CA
Rafai Far; Adel - Mount-Royal CA
Rafai Far; Adel - Ville Mont-Royal N/A CA
Rafai Far; Adel - St. Laurent CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
High purity oritavancin and method of producing same Grant 10,864,249 - Rafai Far , et al. December 15, 2	2020-12-15
High Purity Oritavancin And Method Of Producing Same App 20190290723 - RAFAI FAR; Adel ; et al.	2019-09-26
High purity oritavancin and method of producing same Grant 10,328,118 - Rafai Far , et al.	2019-06-25
Methods of inhibiting and treating biofilms using glycopeptide antibiotics Grant 10,201,587 - Neesham-Grenon , et al. Feb	2019-02-12
Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same Grant 10,039,780 - Dutta , et al. August 7, 2	2018-08-07
Pharmaceutical Formulations Comprising High Purity Cangrelor And Methods For Preparing And Using The Same App 20170304345 - DUTTA; Panna ; et al.	2017-10-26
Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same Grant 9,700,575 - Dutta , et al. July 11, 2	2017-07-11
High Purity Oritavancin And Method Of Producing Same App 20170157206 - RAFAI FAR; Adel ; et al.	2017-06-08
High purity oritavancin and method of producing same Grant 9,649,352 - Rafai Far , et al. May 16, 2	2017-05-16
Pharmaceutical Formulations Comprising High Purity Cangrelor And Methods For Preparing And Using The Same App 20160296549 - DUTTA; Panna ; et al.	2016-10-13
Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same Grant 9,439,921 - Dutta , et al. September 13, 2	2016-09-13
Pharmaceutical Formulations Comprising High Purity Cangrelor And Methods For Preparing And Using The Same App 20160199400 - DUTTA; Panna ; et al.	2016-07-14
Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same Grant 9,295,687 - Dutta , et al. March 29, 2	2016-03-29
High Purity Oritavancin And Method Of Producing Same App 20160015772 - Rafai Far; Adel ; et al.	2016-01-21
Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections Grant 8,946,144 - Tanaka , et al. February 3, 2	2015-02-03
Glycopeptide and lipoglycopeptide antibiotics with improved solubility Grant 8,901,072 - Rafai Far , et al. December 2, 2	2014-12-02
Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections Grant 8,524,691 - Dietrich , et al. September 3, 2	2013-09-03
Phosphonated Rifamycins and uses thereof for the prevention and treatment of bone and joint infections Grant 8,404,664 - Rose , et al. March 26, 2	2013-03-26
Glycopeptide And Lipoglycopeptide Antibiotics With Improved Solubility App 20120149632 - Rafai Far; Adel ; et al.	2012-06-14
Phosphonated Rifamycins And Uses Thereof For The Prevention And Treatment Of Bone And Joint Infections App 20110263534 - Rose; Yannick Stephane ; et al.	2011-10-27
Phosphonated Rifamycins And Uses Thereof For The Prevention And Treatment Of Bone And Joint Infections App 20110178001 - Dietrich; Evelyne ; et al.	2011-07-21
Methods Of Inhibiting And Treating Biofilms Using Glycopeptide Antibiotics App 20110046041 - Neesham-Grenon; Eve ; et al.	2011-02-24
Phosphonated Glycopeptide And Lipoglycopeptide Antibiotics And Uses Thereof For The Prevention And Treatment Of Bone And Joint Infections App 20100113333 - Tanaka; Kelly ; et al.	2010-05-06
Phosphonated Fluoroquinolones, Antibacterial Analogs Thereof, and Methods for the Prevention and Treatment of Bone and Joint Infections App 20080287396 - Delorme; Daniel ; et al.	2008-11-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.